Vigil Neuroscience Acquired by Sanofi Boosts Stock

Vigil Neuroscience shares are trading higher after the company announced a definitive merger agreement to be acquired by Sanofi, offering shareholders up to $10.00 per share, highlighting the value in its Alzheimer's treatment pipeline.